- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Oncolytic Virus will have significant change from previous year. By the most conservative estimates of global Oncolytic Virus market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 16 million in 2020. Over the next five years the Oncolytic Virus market will register a 7.1% CAGR in terms of revenue, the global market size will reach US$ 21 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Imlygic
Oncorine
Others
Imlygic is the most widely used type which takes up about 85% of the total market share in 2019.
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Melanoma
Other Cancers
The application of oncolytic virus therapy includes melanoma and other cancer, and the proportion of sales for melanoma in 2018 is about 85.52%.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Amgen
Shanghai Sunway Biotech
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Consumption 2016-2026
2.1.2 Oncolytic Virus Consumption CAGR by Region
2.2 Oncolytic Virus Segment by Type
2.2.1 Imlygic
2.2.2 Oncorine
2.2.3 Others
2.3 Oncolytic Virus Sales by Type
2.3.1 Global Oncolytic Virus Sales Market Share by Type (2016-2021)
2.3.2 Global Oncolytic Virus Revenue and Market Share by Type (2016-2021)
2.3.3 Global Oncolytic Virus Sale Price by Type (2016-2021)
2.4 Oncolytic Virus Segment by Application
2.4.1 Melanoma
2.4.2 Other Cancers
2.5 Oncolytic Virus Sales by Application
2.5.1 Global Oncolytic Virus Sale Market Share by Application (2016-2021)
2.5.2 Global Oncolytic Virus Revenue and Market Share by Application (2016-2021)
2.5.3 Global Oncolytic Virus Sale Price by Application (2016-2021)
3 Global Oncolytic Virus by Company
3.1 Global Oncolytic Virus Sales Market Share by Company
3.1.1 Global Oncolytic Virus Sales by Company (2019-2021)
3.1.2 Global Oncolytic Virus Sales Market Share by Company (2019-2021)
3.2 Global Oncolytic Virus Revenue Market Share by Company
3.2.1 Global Oncolytic Virus Revenue by Company (2019-2021)
3.2.2 Global Oncolytic Virus Revenue Market Share by Company (2019-2021)
3.3 Global Oncolytic Virus Sale Price by Company
3.4 Global Manufacturers Oncolytic Virus Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncolytic Virus Product Location Distribution
3.4.2 Players Oncolytic Virus Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Oncolytic Virus by Region
4.1 Global Oncolytic Virus by Region
4.1.1 Global Oncolytic Virus Sales by Region
4.1.2 Global Oncolytic Virus Revenue by Region
4.2 Americas Oncolytic Virus Sales Growth
4.3 APAC Oncolytic Virus Sales Growth
4.4 Europe Oncolytic Virus Sales Growth
4.5 Middle East & Africa Oncolytic Virus Sales Growth
5 Americas
5.1 Americas Oncolytic Virus Sales by Country
5.1.1 Americas Oncolytic Virus Sales by Country (2016-2021)
5.1.2 Americas Oncolytic Virus Revenue by Country (2016-2021)
5.2 Americas Oncolytic Virus Sales by Type
5.3 Americas Oncolytic Virus Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncolytic Virus Sales by Region
6.1.1 APAC Oncolytic Virus Sales by Region (2016-2021)
6.1.2 APAC Oncolytic Virus Revenue by Region (2016-2021)
6.2 APAC Oncolytic Virus Sales by Type
6.3 APAC Oncolytic Virus Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oncolytic Virus by Country
7.1.1 Europe Oncolytic Virus Sales by Country (2016-2021)
7.1.2 Europe Oncolytic Virus Revenue by Country (2016-2021)
7.2 Europe Oncolytic Virus Sales by Type
7.3 Europe Oncolytic Virus Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oncolytic Virus by Country
8.1.1 Middle East & Africa Oncolytic Virus Sales by Country (2016-2021)
8.1.2 Middle East & Africa Oncolytic Virus Revenue by Country (2016-2021)
8.2 Middle East & Africa Oncolytic Virus Sales by Type
8.3 Middle East & Africa Oncolytic Virus Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Oncolytic Virus Distributors
10.3 Oncolytic Virus Customer
11 Global Oncolytic Virus Market Forecast
11.1 Global Oncolytic Virus Forecast by Region
11.1.1 Global Oncolytic Virus Forecast by Regions (2021-2026)
11.2.2 Global Oncolytic Virus Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Oncolytic Virus Forecast by Type
11.7 Global Oncolytic Virus Forecast by Application
12 Key Players Analysis
12.1 Amgen
12.1.1 Amgen Company Information
12.1.2 Amgen Oncolytic Virus Product Offered
12.1.3 Amgen Oncolytic Virus Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Amgen Main Business Overview
12.1.5 Amgen Latest Developments
12.2 Shanghai Sunway Biotech
12.2.1 Shanghai Sunway Biotech Company Information
12.2.2 Shanghai Sunway Biotech Oncolytic Virus Product Offered
12.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Shanghai Sunway Biotech Main Business Overview
12.2.5 Shanghai Sunway Biotech Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Oncolytic Virus Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Imlygic
Table 3. Major Players of Oncorine
Table 4. Major Players of Others
Table 5. Global Oncolytic Virus Sales by Type (2016-2021) & (K Units)
Table 6. Global Oncolytic Virus Sales Market Share by Type (2016-2021)
Table 7. Global Oncolytic Virus Revenue by Type (2016-2021) & ($ million)
Table 8. Global Oncolytic Virus Revenue Market Share by Type (2016-2021)
Table 9. Global Oncolytic Virus Sale Price by Type (2016-2021)
Table 10. Global Oncolytic Virus Sales by Application (2016-2021) & (K Units)
Table 11. Global Oncolytic Virus Sales Market Share by Application (2016-2021)
Table 12. Global Oncolytic Virus Value by Application (2016-2021)
Table 13. Global Oncolytic Virus Revenue Market Share by Application (2016-2021)
Table 14. Global Oncolytic Virus Sale Price by Application (2016-2021)
Table 15. Global Oncolytic Virus Sales by Company (2019-2021) & (K Units)
Table 16. Global Oncolytic Virus Sales Market Share by Company (2019-2021)
Table 17. Global Oncolytic Virus Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Oncolytic Virus Revenue Market Share by Company (2019-2021)
Table 19. Global Oncolytic Virus Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Oncolytic Virus Producing Area Distribution and Sales Area
Table 21. Players Oncolytic Virus Products Offered
Table 22. Oncolytic Virus Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oncolytic Virus Sales by Region (2016-2021) (K Units)
Table 26. Global Oncolytic Virus Sales Market Share by Region (2016-2021)
Table 27. Global Oncolytic Virus Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Oncolytic Virus Revenue Market Share by Region (2016-2021)
Table 29. Americas Oncolytic Virus Sales by Country (2016-2021) & (K Units)
Table 30. Americas Oncolytic Virus Sales Market Share by Country (2016-2021)
Table 31. Americas Oncolytic Virus Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Oncolytic Virus Revenue Market Share by Country (2016-2021)
Table 33. Americas Oncolytic Virus Sales by Type (2016-2021) & (K Units)
Table 34. Americas Oncolytic Virus Sales Market Share by Type (2016-2021)
Table 35. Americas Oncolytic Virus Sales by Application (2016-2021) & (K Units)
Table 36. Americas Oncolytic Virus Sales Market Share by Application (2016-2021)
Table 37. APAC Oncolytic Virus Sales by Region (2016-2021) & (K Units)
Table 38. APAC Oncolytic Virus Sales Market Share by Region (2016-2021)
Table 39. APAC Oncolytic Virus Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Oncolytic Virus Revenue Market Share by Region (2016-2021)
Table 41. APAC Oncolytic Virus Sales by Type (2016-2021) & (K Units)
Table 42. APAC Oncolytic Virus Sales Market Share by Type (2016-2021)
Table 43. APAC Oncolytic Virus Sales by Application (2016-2021) & (K Units)
Table 44. APAC Oncolytic Virus Sales Market Share by Application (2016-2021)
Table 45. Europe Oncolytic Virus Sales by Country (2016-2021) & (K Units)
Table 46. Europe Oncolytic Virus Sales Market Share by Country (2016-2021)
Table 47. Europe Oncolytic Virus Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Oncolytic Virus Revenue Market Share by Country (2016-2021)
Table 49. Europe Oncolytic Virus Sales by Type (2016-2021) & (K Units)
Table 50. Europe Oncolytic Virus Sales Market Share by Type (2016-2021)
Table 51. Europe Oncolytic Virus Sales by Application (2016-2021) & (K Units)
Table 52. Europe Oncolytic Virus Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Oncolytic Virus Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Oncolytic Virus Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Oncolytic Virus Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Oncolytic Virus Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Oncolytic Virus Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Oncolytic Virus Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Oncolytic Virus Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Oncolytic Virus Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Oncolytic Virus
Table 62. Key Application and Potential Industries of Oncolytic Virus
Table 63. Key Challenges of Oncolytic Virus
Table 64. Key Trends of Oncolytic Virus
Table 65. Oncolytic Virus Distributors List
Table 66. Oncolytic Virus Customer List
Table 67. Global Oncolytic Virus Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Oncolytic Virus Consumption Market Forecast by Region
Table 69. Global Oncolytic Virus Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Oncolytic Virus Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Oncolytic Virus Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Oncolytic Virus Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Oncolytic Virus Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Oncolytic Virus Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Oncolytic Virus Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Oncolytic Virus Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Oncolytic Virus Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Oncolytic Virus Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Oncolytic Virus Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Oncolytic Virus Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Oncolytic Virus Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Oncolytic Virus Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Oncolytic Virus Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Oncolytic Virus Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Oncolytic Virus Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Oncolytic Virus Revenue Market Share Forecast by Application (2021-2026)
Table 87. Amgen Basic Information, Oncolytic Virus Manufacturing Base, Sales Area and Its Competitors
Table 88. Amgen Oncolytic Virus Product Offered
Table 89. Amgen Oncolytic Virus Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Amgen Main Business
Table 91. Amgen Latest Developments
Table 92. Shanghai Sunway Biotech Basic Information, Oncolytic Virus Manufacturing Base, Sales Area and Its Competitors
Table 93. Shanghai Sunway Biotech Oncolytic Virus Product Offered
Table 94. Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. Shanghai Sunway Biotech Main Business
Table 96. Shanghai Sunway Biotech Latest Developments
List of Figures
Figure 1. Picture of Oncolytic Virus
Figure 2. Oncolytic Virus Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncolytic Virus Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Oncolytic Virus Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Oncolytic Virus Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Imlygic
Figure 10. Product Picture of Oncorine
Figure 11. Product Picture of Others
Figure 12. Global Oncolytic Virus Sales Market Share by Type in 2020
Figure 13. Global Oncolytic Virus Revenue Market Share by Type (2016-2021)
Figure 14. Oncolytic Virus Consumed in Melanoma
Figure 15. Global Oncolytic Virus Market: Melanoma (2016-2021) & (K Units)
Figure 16. Oncolytic Virus Consumed in Other Cancers
Figure 17. Global Oncolytic Virus Market: Other Cancers (2016-2021) & (K Units)
Figure 18. Global Oncolytic Virus Sales Market Share by Application (2016-2021)
Figure 19. Global Oncolytic Virus Revenue Market Share by Application in 2020
Figure 20. Oncolytic Virus Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Oncolytic Virus Revenue Market Share by Company in 2020
Figure 22. Global Oncolytic Virus Sales Market Share by Regions (2016-2021)
Figure 23. Global Oncolytic Virus Revenue Market Share by Region in 2020
Figure 24. Americas Oncolytic Virus Sales 2016-2021 (K Units)
Figure 25. Americas Oncolytic Virus Revenue 2016-2021 ($ Millions)
Figure 26. APAC Oncolytic Virus Sales 2016-2021 (K Units)
Figure 27. APAC Oncolytic Virus Revenue 2016-2021 ($ Millions)
Figure 28. Europe Oncolytic Virus Sales 2016-2021 (K Units)
Figure 29. Europe Oncolytic Virus Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Oncolytic Virus Sales 2016-2021 (K Units)
Figure 31. Middle East & Africa Oncolytic Virus Revenue 2016-2021 ($ Millions)
Figure 32. Americas Oncolytic Virus Sales Market Share by Country in 2020
Figure 33. Americas Oncolytic Virus Revenue Market Share by Country in 2020
Figure 34. Americas Oncolytic Virus Sales Market Share by Type in 2020
Figure 35. Americas Oncolytic Virus Sales Market Share by Application in 2020
Figure 36. United States Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Oncolytic Virus Sales Market Share by Region in 2020
Figure 41. APAC Oncolytic Virus Revenue Market Share by Regions in 2020
Figure 42. APAC Oncolytic Virus Sales Market Share by Type in 2020
Figure 43. APAC Oncolytic Virus Sales Market Share by Application in 2020
Figure 44. China Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Oncolytic Virus Sales Market Share by Country in 2020
Figure 51. Europe Oncolytic Virus Revenue Market Share by Country in 2020
Figure 52. Europe Oncolytic Virus Sales Market Share by Type in 2020
Figure 53. Europe Oncolytic Virus Sales Market Share by Application in 2020
Figure 54. Germany Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Oncolytic Virus Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Oncolytic Virus Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Oncolytic Virus Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Oncolytic Virus Sales Market Share by Application in 2020
Figure 63. Egypt Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Oncolytic Virus Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
